Revised FIGO staging for carcinoma of the cervix uteri
Objective To revise FIGO staging of carcinoma of the cervix uteri, allowing incorporation of imaging and/or pathological findings, and clinical assessment of tumor size and disease extent. Methods Review of literature and consensus view of the FIGO Gynecologic Oncology Committee and related societie...
Gespeichert in:
| Veröffentlicht in: | International journal of gynecology and obstetrics 2019-04, Vol.145 (1), p.129-135 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 135 |
|---|---|
| container_issue | 1 |
| container_start_page | 129 |
| container_title | International journal of gynecology and obstetrics |
| container_volume | 145 |
| creator | Bhatla, Neerja Berek, Jonathan S. Cuello Fredes, Mauricio Denny, Lynette A. Grenman, Seija Karunaratne, Kanishka Kehoe, Sean T. Konishi, Ikuo Olawaiye, Alexander B. Prat, Jaime Sankaranarayanan, Rengaswamy |
| description | Objective
To revise FIGO staging of carcinoma of the cervix uteri, allowing incorporation of imaging and/or pathological findings, and clinical assessment of tumor size and disease extent.
Methods
Review of literature and consensus view of the FIGO Gynecologic Oncology Committee and related societies and organizations.
Results
In stage I, revision of the definition of microinvasion and lesion size as follows. Stage IA: lateral extension measurement is removed; stage IB has three subgroups—stage IB1: invasive carcinomas ≥5 mm and |
| doi_str_mv | 10.1002/ijgo.12749 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179394773</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179394773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4369-42c0fd1d795ddcc6c5c66b7393f3c7cdec0b4732263da4c2c9af2cf85d0875cd3</originalsourceid><addsrcrecordid>eNp9kE9PwjAchhujEUQvfgCzozEZ9t9aejREEENCYvTclF87LNkYthvKt3c49OjpPbxPnsOD0DXBQ4IxvffrVTUkVHJ1gvpkJFXKuFSnqN-eOJVU0R66iHGNMSaSkHPUY1hkQvCsj8SL2_nobDKZTRdJrM3Kb1ZJXoUETAC_qUqTVHlSv7sEXNj5r6SpXfCX6Cw3RXRXxx2gt8nj6_gpnS-ms_HDPAXOhEo5BZxbYqXKrAUQkIEQS8kUyxlIsA7wkktGqWDWcKCgTE4hH2UWj2QGlg3QbefdhuqjcbHWpY_gisJsXNVETYlUTHEpWYvedSiEKsbgcr0NvjRhrwnWh0760En_dGrhm6O3WZbO_qG_YVqAdMCnL9z-H5WePU8XnfQbF8xyDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179394773</pqid></control><display><type>article</type><title>Revised FIGO staging for carcinoma of the cervix uteri</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Bhatla, Neerja ; Berek, Jonathan S. ; Cuello Fredes, Mauricio ; Denny, Lynette A. ; Grenman, Seija ; Karunaratne, Kanishka ; Kehoe, Sean T. ; Konishi, Ikuo ; Olawaiye, Alexander B. ; Prat, Jaime ; Sankaranarayanan, Rengaswamy</creator><creatorcontrib>Bhatla, Neerja ; Berek, Jonathan S. ; Cuello Fredes, Mauricio ; Denny, Lynette A. ; Grenman, Seija ; Karunaratne, Kanishka ; Kehoe, Sean T. ; Konishi, Ikuo ; Olawaiye, Alexander B. ; Prat, Jaime ; Sankaranarayanan, Rengaswamy</creatorcontrib><description>Objective
To revise FIGO staging of carcinoma of the cervix uteri, allowing incorporation of imaging and/or pathological findings, and clinical assessment of tumor size and disease extent.
Methods
Review of literature and consensus view of the FIGO Gynecologic Oncology Committee and related societies and organizations.
Results
In stage I, revision of the definition of microinvasion and lesion size as follows. Stage IA: lateral extension measurement is removed; stage IB has three subgroups—stage IB1: invasive carcinomas ≥5 mm and <2 cm in greatest diameter; stage IB2: tumors 2–4 cm; stage IB3: tumors ≥4 cm. Imaging or pathology findings may be used to assess retroperitoneal lymph nodes; if metastatic, the case is assigned stage IIIC; if only pelvic lymph nodes, the case is assigned stage IIIC1; if para‐aortic nodes are involved, the case is assigned stage IIIC2. Notations ‘r’ and ‘p’ will indicate the method used to derive the stage—i.e., imaging or pathology, respectively—and should be recorded. Routine investigations and other methods (e.g., examination under anesthesia, cystoscopy, proctoscopy, etc.) are not mandatory and are to be recommended based on clinical findings and standard of care.
Conclusion
The revised cervical cancer staging is applicable to all resource levels. Data collection and publication will inform future revisions.
The 2018 FIGO cervical cancer staging system allows use of imaging/pathology for stage allocation, and increases subgroups in stages I and III.</description><identifier>ISSN: 0020-7292</identifier><identifier>EISSN: 1879-3479</identifier><identifier>DOI: 10.1002/ijgo.12749</identifier><identifier>PMID: 30656645</identifier><language>eng</language><publisher>United States</publisher><subject>Cancer ; Carcinoma ; Carcinoma - diagnostic imaging ; Carcinoma - pathology ; Cervix ; Disease Progression ; Female ; FIGO ; Humans ; Imaging ; Lymphatic Metastasis - diagnostic imaging ; Lymphatic Metastasis - pathology ; Neoplasm Invasiveness ; Neoplasm Staging ; Retrospective Studies ; Revised ; Staging ; Uterine Cervical Neoplasms - diagnostic imaging ; Uterine Cervical Neoplasms - pathology</subject><ispartof>International journal of gynecology and obstetrics, 2019-04, Vol.145 (1), p.129-135</ispartof><rights>2019 International Federation of Gynecology and Obstetrics</rights><rights>2019 International Federation of Gynecology and Obstetrics.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4369-42c0fd1d795ddcc6c5c66b7393f3c7cdec0b4732263da4c2c9af2cf85d0875cd3</citedby><cites>FETCH-LOGICAL-c4369-42c0fd1d795ddcc6c5c66b7393f3c7cdec0b4732263da4c2c9af2cf85d0875cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijgo.12749$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijgo.12749$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30656645$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhatla, Neerja</creatorcontrib><creatorcontrib>Berek, Jonathan S.</creatorcontrib><creatorcontrib>Cuello Fredes, Mauricio</creatorcontrib><creatorcontrib>Denny, Lynette A.</creatorcontrib><creatorcontrib>Grenman, Seija</creatorcontrib><creatorcontrib>Karunaratne, Kanishka</creatorcontrib><creatorcontrib>Kehoe, Sean T.</creatorcontrib><creatorcontrib>Konishi, Ikuo</creatorcontrib><creatorcontrib>Olawaiye, Alexander B.</creatorcontrib><creatorcontrib>Prat, Jaime</creatorcontrib><creatorcontrib>Sankaranarayanan, Rengaswamy</creatorcontrib><title>Revised FIGO staging for carcinoma of the cervix uteri</title><title>International journal of gynecology and obstetrics</title><addtitle>Int J Gynaecol Obstet</addtitle><description>Objective
To revise FIGO staging of carcinoma of the cervix uteri, allowing incorporation of imaging and/or pathological findings, and clinical assessment of tumor size and disease extent.
Methods
Review of literature and consensus view of the FIGO Gynecologic Oncology Committee and related societies and organizations.
Results
In stage I, revision of the definition of microinvasion and lesion size as follows. Stage IA: lateral extension measurement is removed; stage IB has three subgroups—stage IB1: invasive carcinomas ≥5 mm and <2 cm in greatest diameter; stage IB2: tumors 2–4 cm; stage IB3: tumors ≥4 cm. Imaging or pathology findings may be used to assess retroperitoneal lymph nodes; if metastatic, the case is assigned stage IIIC; if only pelvic lymph nodes, the case is assigned stage IIIC1; if para‐aortic nodes are involved, the case is assigned stage IIIC2. Notations ‘r’ and ‘p’ will indicate the method used to derive the stage—i.e., imaging or pathology, respectively—and should be recorded. Routine investigations and other methods (e.g., examination under anesthesia, cystoscopy, proctoscopy, etc.) are not mandatory and are to be recommended based on clinical findings and standard of care.
Conclusion
The revised cervical cancer staging is applicable to all resource levels. Data collection and publication will inform future revisions.
The 2018 FIGO cervical cancer staging system allows use of imaging/pathology for stage allocation, and increases subgroups in stages I and III.</description><subject>Cancer</subject><subject>Carcinoma</subject><subject>Carcinoma - diagnostic imaging</subject><subject>Carcinoma - pathology</subject><subject>Cervix</subject><subject>Disease Progression</subject><subject>Female</subject><subject>FIGO</subject><subject>Humans</subject><subject>Imaging</subject><subject>Lymphatic Metastasis - diagnostic imaging</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Staging</subject><subject>Retrospective Studies</subject><subject>Revised</subject><subject>Staging</subject><subject>Uterine Cervical Neoplasms - diagnostic imaging</subject><subject>Uterine Cervical Neoplasms - pathology</subject><issn>0020-7292</issn><issn>1879-3479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9PwjAchhujEUQvfgCzozEZ9t9aejREEENCYvTclF87LNkYthvKt3c49OjpPbxPnsOD0DXBQ4IxvffrVTUkVHJ1gvpkJFXKuFSnqN-eOJVU0R66iHGNMSaSkHPUY1hkQvCsj8SL2_nobDKZTRdJrM3Kb1ZJXoUETAC_qUqTVHlSv7sEXNj5r6SpXfCX6Cw3RXRXxx2gt8nj6_gpnS-ms_HDPAXOhEo5BZxbYqXKrAUQkIEQS8kUyxlIsA7wkktGqWDWcKCgTE4hH2UWj2QGlg3QbefdhuqjcbHWpY_gisJsXNVETYlUTHEpWYvedSiEKsbgcr0NvjRhrwnWh0760En_dGrhm6O3WZbO_qG_YVqAdMCnL9z-H5WePU8XnfQbF8xyDQ</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Bhatla, Neerja</creator><creator>Berek, Jonathan S.</creator><creator>Cuello Fredes, Mauricio</creator><creator>Denny, Lynette A.</creator><creator>Grenman, Seija</creator><creator>Karunaratne, Kanishka</creator><creator>Kehoe, Sean T.</creator><creator>Konishi, Ikuo</creator><creator>Olawaiye, Alexander B.</creator><creator>Prat, Jaime</creator><creator>Sankaranarayanan, Rengaswamy</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201904</creationdate><title>Revised FIGO staging for carcinoma of the cervix uteri</title><author>Bhatla, Neerja ; Berek, Jonathan S. ; Cuello Fredes, Mauricio ; Denny, Lynette A. ; Grenman, Seija ; Karunaratne, Kanishka ; Kehoe, Sean T. ; Konishi, Ikuo ; Olawaiye, Alexander B. ; Prat, Jaime ; Sankaranarayanan, Rengaswamy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4369-42c0fd1d795ddcc6c5c66b7393f3c7cdec0b4732263da4c2c9af2cf85d0875cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cancer</topic><topic>Carcinoma</topic><topic>Carcinoma - diagnostic imaging</topic><topic>Carcinoma - pathology</topic><topic>Cervix</topic><topic>Disease Progression</topic><topic>Female</topic><topic>FIGO</topic><topic>Humans</topic><topic>Imaging</topic><topic>Lymphatic Metastasis - diagnostic imaging</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Staging</topic><topic>Retrospective Studies</topic><topic>Revised</topic><topic>Staging</topic><topic>Uterine Cervical Neoplasms - diagnostic imaging</topic><topic>Uterine Cervical Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhatla, Neerja</creatorcontrib><creatorcontrib>Berek, Jonathan S.</creatorcontrib><creatorcontrib>Cuello Fredes, Mauricio</creatorcontrib><creatorcontrib>Denny, Lynette A.</creatorcontrib><creatorcontrib>Grenman, Seija</creatorcontrib><creatorcontrib>Karunaratne, Kanishka</creatorcontrib><creatorcontrib>Kehoe, Sean T.</creatorcontrib><creatorcontrib>Konishi, Ikuo</creatorcontrib><creatorcontrib>Olawaiye, Alexander B.</creatorcontrib><creatorcontrib>Prat, Jaime</creatorcontrib><creatorcontrib>Sankaranarayanan, Rengaswamy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhatla, Neerja</au><au>Berek, Jonathan S.</au><au>Cuello Fredes, Mauricio</au><au>Denny, Lynette A.</au><au>Grenman, Seija</au><au>Karunaratne, Kanishka</au><au>Kehoe, Sean T.</au><au>Konishi, Ikuo</au><au>Olawaiye, Alexander B.</au><au>Prat, Jaime</au><au>Sankaranarayanan, Rengaswamy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Revised FIGO staging for carcinoma of the cervix uteri</atitle><jtitle>International journal of gynecology and obstetrics</jtitle><addtitle>Int J Gynaecol Obstet</addtitle><date>2019-04</date><risdate>2019</risdate><volume>145</volume><issue>1</issue><spage>129</spage><epage>135</epage><pages>129-135</pages><issn>0020-7292</issn><eissn>1879-3479</eissn><abstract>Objective
To revise FIGO staging of carcinoma of the cervix uteri, allowing incorporation of imaging and/or pathological findings, and clinical assessment of tumor size and disease extent.
Methods
Review of literature and consensus view of the FIGO Gynecologic Oncology Committee and related societies and organizations.
Results
In stage I, revision of the definition of microinvasion and lesion size as follows. Stage IA: lateral extension measurement is removed; stage IB has three subgroups—stage IB1: invasive carcinomas ≥5 mm and <2 cm in greatest diameter; stage IB2: tumors 2–4 cm; stage IB3: tumors ≥4 cm. Imaging or pathology findings may be used to assess retroperitoneal lymph nodes; if metastatic, the case is assigned stage IIIC; if only pelvic lymph nodes, the case is assigned stage IIIC1; if para‐aortic nodes are involved, the case is assigned stage IIIC2. Notations ‘r’ and ‘p’ will indicate the method used to derive the stage—i.e., imaging or pathology, respectively—and should be recorded. Routine investigations and other methods (e.g., examination under anesthesia, cystoscopy, proctoscopy, etc.) are not mandatory and are to be recommended based on clinical findings and standard of care.
Conclusion
The revised cervical cancer staging is applicable to all resource levels. Data collection and publication will inform future revisions.
The 2018 FIGO cervical cancer staging system allows use of imaging/pathology for stage allocation, and increases subgroups in stages I and III.</abstract><cop>United States</cop><pmid>30656645</pmid><doi>10.1002/ijgo.12749</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0020-7292 |
| ispartof | International journal of gynecology and obstetrics, 2019-04, Vol.145 (1), p.129-135 |
| issn | 0020-7292 1879-3479 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2179394773 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Cancer Carcinoma Carcinoma - diagnostic imaging Carcinoma - pathology Cervix Disease Progression Female FIGO Humans Imaging Lymphatic Metastasis - diagnostic imaging Lymphatic Metastasis - pathology Neoplasm Invasiveness Neoplasm Staging Retrospective Studies Revised Staging Uterine Cervical Neoplasms - diagnostic imaging Uterine Cervical Neoplasms - pathology |
| title | Revised FIGO staging for carcinoma of the cervix uteri |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A18%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Revised%20FIGO%20staging%20for%20carcinoma%20of%20the%20cervix%20uteri&rft.jtitle=International%20journal%20of%20gynecology%20and%20obstetrics&rft.au=Bhatla,%20Neerja&rft.date=2019-04&rft.volume=145&rft.issue=1&rft.spage=129&rft.epage=135&rft.pages=129-135&rft.issn=0020-7292&rft.eissn=1879-3479&rft_id=info:doi/10.1002/ijgo.12749&rft_dat=%3Cproquest_cross%3E2179394773%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179394773&rft_id=info:pmid/30656645&rfr_iscdi=true |